IL139616D0 - Recombinant (alpha)-l-iduronidase, methods for producing and purifying the same and methods for treating, diseases caused by deficiencies thereof - Google Patents

Recombinant (alpha)-l-iduronidase, methods for producing and purifying the same and methods for treating, diseases caused by deficiencies thereof

Info

Publication number
IL139616D0
IL139616D0 IL13961699A IL13961699A IL139616D0 IL 139616 D0 IL139616 D0 IL 139616D0 IL 13961699 A IL13961699 A IL 13961699A IL 13961699 A IL13961699 A IL 13961699A IL 139616 D0 IL139616 D0 IL 139616D0
Authority
IL
Israel
Prior art keywords
methods
iduronidase
deficiencies
purifying
recombinant
Prior art date
Application number
IL13961699A
Original Assignee
Harbor Ucla
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US7820998A priority Critical
Priority to US17097798A priority
Application filed by Harbor Ucla filed Critical Harbor Ucla
Priority to PCT/US1999/010102 priority patent/WO1999058691A2/en
Publication of IL139616D0 publication Critical patent/IL139616D0/en

Links

IL13961699A 1998-05-13 1999-05-07 Recombinant (alpha)-l-iduronidase, methods for producing and purifying the same and methods for treating, diseases caused by deficiencies thereof IL139616D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US7820998A true 1998-05-13 1998-05-13
US17097798A true 1998-10-13 1998-10-13
PCT/US1999/010102 WO1999058691A2 (en) 1998-05-13 1999-05-07 Recombinant (alpha)-l-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof

Publications (1)

Publication Number Publication Date
IL139616D0 true IL139616D0 (en) 2002-02-10

Family

ID=26760239

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13961699A IL139616D0 (en) 1998-05-13 1999-05-07 Recombinant (alpha)-l-iduronidase, methods for producing and purifying the same and methods for treating, diseases caused by deficiencies thereof

Country Status (8)

Country Link
EP (1) EP1078075A2 (en)
JP (1) JP2002514429A (en)
CN (1) CN1300323A (en)
AU (1) AU4072499A (en)
BR (1) BR9910323A (en)
CA (1) CA2328518A1 (en)
IL (1) IL139616D0 (en)
WO (1) WO1999058691A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6585971B1 (en) 1999-11-12 2003-07-01 Harbor-Ucla Research And Education Institute Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating disease caused by deficiencies thereof
US6426208B1 (en) 1999-11-12 2002-07-30 Harbor-Ucla Research And Education Institute Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
US6569661B1 (en) * 1999-11-12 2003-05-27 Biomarin Pharmaceutical Inc. Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
EP3449934A1 (en) 2000-07-18 2019-03-06 Duke University Treatment of glycogen storage disease type ii
US7442372B2 (en) * 2003-08-29 2008-10-28 Biomarin Pharmaceutical Inc. Delivery of therapeutic compounds to the brain and other tissues
CN103180445B (en) * 2010-10-22 2018-02-16 库尔纳公司 By inhibiting α-L- iduronic acid enzyme (IDUA) natural antisense transcripts treating related diseases IDUA
CN103487414A (en) * 2012-06-14 2014-01-01 北京和信非凡生物技术有限公司 Method, substrate and reagents for alpha-L-iduronidase activity detection
MX2015012739A (en) * 2013-03-15 2016-02-19 Univ Pennsylvania Compositions and methods for treating mpsi.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2099503C (en) * 1991-11-14 2007-10-09 Hamish Steele Scott Synthetic alpha-l-iduronidase and genetic sequences encoding same
WO1997010353A1 (en) * 1995-09-14 1997-03-20 Virginia Tech Intellectual Property, Inc. Production of lysosomal enzymes in plant-based expression systems

Also Published As

Publication number Publication date
CN1300323A (en) 2001-06-20
AU4072499A (en) 1999-11-29
WO1999058691A3 (en) 2000-02-17
WO1999058691A2 (en) 1999-11-18
CA2328518A1 (en) 1999-11-18
EP1078075A2 (en) 2001-02-28
JP2002514429A (en) 2002-05-21
BR9910323A (en) 2001-01-30

Similar Documents

Publication Publication Date Title
GB2363756B (en) Absorbent structure and method for production
GB2311249B (en) Composite sheet,absorbent article and process for producing the same
SG105513A1 (en) Low defect density, ideal oxygen precipitating silicon
GB9823873D0 (en) 2-ureido-thiazole derivatives,process for their preparation,and their use as antitumour agents
DE69939022D1 (en) Epidermal growth factor receptor antagonists for the treatment greatly increased mucus secretion in the lungs
AU4899997A (en) Purine l-nucleosides, analogs and uses thereof
ZA9703155B (en) Exhaust gas treatment system.
HU9802224D0 (en) Pyrazol derivatives, process for producing them and their use as medicament
IL203524A (en) Isolated steap-1 polypeptide, composition comprising it, process for its production and uses thereof
AU5093399A (en) Hemofiltration systems, methods, and devices used to treat inflammatory mediatorrelated disease
SG65087A1 (en) Bromine-impregnated activated carbon and process for preparing the same
PL319454A1 (en) Naphtyl compounds, intermediate compounds, processes, means and methods
ZA9900016B (en) Process for purifying air by adsorption before cryogenic distillation.
IL133366A (en) 4-Phenylpiperidine compounds, process for their preparation and uses thereof
MXPA01003873A (en) Modified peptides as therapeutic agents.
HK1097776A1 (en) ß-L-2'-DEOXY-NUCLEOSIDES FOR THE TREATMENT OF HEPATITIS B
AU5035101A (en) Absorbent structure and method for producing the same
ZA200106449B (en) Absorbent articles and methods for producing the same.
TW358386U (en) Exhaust gas treatment unit
GB9907461D0 (en) Neurite regeneration
AU2856499A (en) Novel substances kf-1040t4a, kf-1040t4b, kf-1040t5a and kf-1040t5b and process for producing the same
SG101989A1 (en) Catalyst composition and process for making same
PT1595670E (en) Method for producing and treating novel elastomer composites and elastomer composites
HU0401081A3 (en) Novel 1,2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and their use
HU0100221A3 (en) Sustained release compositions, process for producing the same and utilization thereof